Alyeska Investment Group
HOWL icon

Alyeska Investment Group’s Werewolf Therapeutics HOWL Stock Holding History

Alyeska Investment Group’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Hold
86,554
– – ﹤0.01% 652
2026
Q1 		$72.1K Sell
86,554
-149,151
-63% -$102K ﹤0.01% 604
2025
Q4 		$149K Hold
235,705
– – ﹤0.01% 575
2025
Q3 		$464K Hold
235,705
– – ﹤0.01% 562
2025
Q2 		$257K Hold
235,705
– – ﹤0.01% 536
2025
Q1 		$229K Hold
235,705
– – ﹤0.01% 485
2024
Q4 		$349K Hold
235,705
– – ﹤0.01% 529
2024
Q3 		$500K Hold
235,705
– – ﹤0.01% 486
2024
Q2 		$575K Hold
235,705
– – ﹤0.01% 495
2024
Q1 		$1.53M Sell
235,705
-200,000
-46% -$1.17M 0.01% 396
2023
Q4 		$1.68M Buy
435,705
+37,897
+10% +$96.8K 0.01% 382
2023
Q3 		$851K Hold
397,808
– – 0.01% 427
2023
Q2 		$1.21M Hold
397,808
– – 0.01% 443
2023
Q1 		$1.03M Buy
397,808
+191,607
+93% +$571K 0.01% 391
2022
Q4 		$423K Hold
206,201
– – ﹤0.01% 378
2022
Q3 		$930K Hold
206,201
– – 0.01% 344
2022
Q2 		$843K Hold
206,201
– – 0.01% 505
2022
Q1 		$907K Hold
206,201
– – 0.01% 527
2021
Q4 		$2.46M Hold
206,201
– – 0.03% 413
2021
Q3 		$3.54M Hold
206,201
– – 0.04% 394
2021
Q2 		$3.6M Buy
+206,201
New +$2.82M 0.04% 410

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alyeska Investment Group's HOWL Position: Q2 2026 in Review

Alyeska Investment Group held its Werewolf Therapeutics (HOWL) position steady in Q2 2026 at 86,554 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Alyeska Investment Group first reported a position in HOWL in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.6M in Q2 2021. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

  • Alyeska Investment Group held 86,554 shares of Werewolf Therapeutics worth $31.2K as of Q2 2026.
  • Alyeska Investment Group left its Werewolf Therapeutics share count unchanged in Q2 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #652 holding.
  • Alyeska Investment Group first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Alyeska Investment Group's Werewolf Therapeutics position peaked at $3.6M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.